<DOC>
	<DOC>NCT01106274</DOC>
	<brief_summary>Recently, riboflavin (0.1%) and ultraviolet-A (UVA) collagen cross-linking (C3R) has shown potential to improve the signs and symptoms of bullous keratopathy .The objective of this study is to demonstrate the effects of C3R to treat bullous keratopathy.</brief_summary>
	<brief_title>The Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking on the Signs and Symptoms of Bullous Keratopathy</brief_title>
	<detailed_description />
	<mesh_term>Corneal Edema</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<criteria>patients with bollous keratopathy corneal scarring or contemporary eye disease affecting VA were excluded.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>